New year, new Veeda. The India-based CRO formerly known as Veeda Group has kicked off 2025 with a brand makeover.

Vancouver, Canada, Jan. 07, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on discovery and development of novel ...

(Reuters) - Biotech firm Maze Therapeutics, backed by Third Rock Ventures, revealed a profit for the first nine months of ...

Clinical Cancer Research publishes articles that focus on innovative clinical and translational research bridging the laboratory and the clinic. Topics include targeted therapies; mechanisms of drug ...

Vancouver, Canada, Jan. 06, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel ...

New study links more spherical heart shapes to higher likelihood of atrial fibrillation and identifies 14 new genes ...

The biotechnology market experiences significant growth, fueled by advancements in genetic therapies and supportive global ...

“During the operations, ISIS fighters engaged coalition forces on several occasions,” CENTCOM said. Those engagements ...

Quantum-Si's NGPS technology disrupts protein analysis market, but recent equity raise and execution risks lead to Sell ...

Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) ("Clearmind" or the "Company"), a clinical-stage biotech company focused on discovery and development ...

Roche's strategic changes in drug development and M&A activity may drive future growth, despite recent setbacks in clinical ...

NORTHAMPTON, MA / ACCESSWIRE / January 6, 2025 / Clinical trials are essential for the development of health care products, and it is increasingly recognized that there is a need for more diversity in ...